Medscape Medical NewsAll articles

BriefCase-Quantification

Aidoc Medical, Ltd. • Radiology • 11/08/2023

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

The BriefCase-Quantification software is designed to assist medical specialists by employing an AI-driven, deep-learning algorithm to automatically measure the maximum axial diameter of the abdominal aorta from contrast-enhanced CT DICOM images. Its methodology relies on cloud-based processing and provides an adjunctive quantitative assessment intended to streamline radiological workflow, with performance validated by a mean absolute error of 1.95 mm in a multicenter study.

Summary

BriefCase-Quantification by Aidoc Medical, Ltd. is a cloud-based radiological image management and processing software designed to assist medical specialists in analyzing CT exams with contrast of the abdominal aorta in adults (18+). Its primary function is to provide an automated measurement of the maximum abdominal aortic axial diameter for normal and aneurysmal aortas, excluding post-operative cases. The software utilizes an artificial intelligence, deep-learning algorithm that processes filtered DICOM images chronologically. After AI processing, the system generates a preview image annotated with the diameter measurement, which is then sent to an image review software and PACS for user review, emphasizing that these measurements are unofficial and require confirmation by a radiologist. The core science of BriefCase-Quantification lies in its AI-driven algorithm that identifies and measures the abdominal aorta from CT scan series. The device's performance was validated in a retrospective, blinded, multicenter study involving 160 cases from six US clinical sites. The study compared the software's measurements against a ground truth established by three board-certified radiologists. The primary endpoint was successfully achieved, with the software demonstrating a mean absolute error of 1.95 mm (95% CI: 1.59 mm, 2.32 mm) compared to the ground truth. This performance was deemed comparable to a reference device, supporting its utility as an aid in quantitative image analysis, though not as a standalone diagnostic tool.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Abdominal AortaCT ScanAI AlgorithmDeep LearningImage ProcessingDiameter MeasurementDICOMRadiologyCloud-basedAneurysm

Device Metadata

Submission Number
K230534
Company
Aidoc Medical, Ltd.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. How does the algorithm differentiate between normal and aneurysmal abdominal aortas, and what is its sensitivity and specificity for detecting aneurysms based on the measured diameter?; What were the specific criteria for case selection in the pivotal study, particularly regarding the range of aortic diameters and the prevalence of aneurysmal versus normal aortas?; Given the mean absolute error of 1.95 mm, what is the clinical impact of this potential measurement discrepancy on patient management, especially for aortas near critical diameter thresholds for intervention?; How does the software's performance vary across different CT scanner manufacturers (Siemens, GE, Philips, Toshiba) and image reconstruction techniques beyond what was detailed in the pivotal study summary?; Beyond maximum axial diameter, does the BriefCase-Quantification software offer or plan to offer any other morphological assessments of the abdominal aorta, such as length, tortuosity, or thrombus burden?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score10/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(deep learning, algorithm, ground truth)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(cloud)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
BriefCase-Quantification - Aidoc Medical, Ltd. | ESL FDA AI Device Intelligence